Biocon gains 1% on launch of Everolimus tablets, a generic version of Afinitor in US

Share
AuthorPosted at
The commercial launch of Everolimus follows an US FDA approval in February 2021.

from India Infoline News Service https://ift.tt/3DdNbcz
Post a Comment
Labels

Comments